Remedy Meds for Weight Loss: Program, Meds, and Oversight

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Part of the PlexusDx Education Hub, where GLP-1 weight-loss options are explained alongside the genetics that influence them. Browse all Peptides & GLP-1 education

Full head-to-head: PlexusDx vs Remedy Meds →

This independent editorial review carries no commercial tie to Remedy Meds, no affiliate links, and no compensation of any kind.

People searching for a GLP-1 weight-loss program want to know what they are signing up for: which medications, which providers, and what happens after the first prescription. This review lays out the Remedy Meds weight-loss model as of July 2026, offered as fair-balance context rather than a recommendation to enroll.

The weight-loss model at a glance

Remedy Meds combines telehealth with a 503A compounding pharmacy. A licensed provider evaluates you virtually, and if you qualify, a prescription is routed either to a retail pharmacy for an FDA-approved brand product or to a compounding pharmacy for compounded semaglutide or tirzepatide. The program is designed around ongoing subscription care rather than a one-time fill.

Which medications are in play

Weight-loss prescribing in this model draws on the incretin class: GLP-1 receptor agonists such as semaglutide, liraglutide, and dulaglutide, and the dual GIP/GLP-1 agonist tirzepatide. The evidence base includes the STEP program for semaglutide (NEJM, 2021) and the SURMOUNT program for tirzepatide (NEJM, 2022), with SURMOUNT-OSA extending tirzepatide study into obstructive sleep apnea (NEJM, 2024). Endpoints vary, and so do individual results.

How oversight and follow-up work

After the initial prescription, telehealth follow-up supports dose titration and side-effect management. Provider type can differ across programs, from physicians to nurse practitioners or physician assistants, and the pharmacy partner may be retail or compounded. As of the July 2026 capture, Remedy publicly lists a microdose tier at $189 per month for compounded semaglutide or tirzepatide, with standard-dose pricing revealed after the intake quiz. Verify specifics at Remedy Meds's official website.

What to confirm before enrolling

Before committing to a weight-loss subscription, it helps to confirm a few specifics: which compound a plan actually dispenses, whether that product is brand or compounded, how dose increases are handled, and what the follow-up schedule includes. Those details shape both the experience and the cost, and they live on the brand's own site rather than in third-party summaries.

Why the same medication produces different results

Two people on identical prescriptions often experience weight loss differently, and part of the reason is genetic. Variants in FTO (fat-mass and obesity-associated), MC4R (a receptor central to satiety and energy balance), GLP1R (the GLP-1 receptor targeted by these compounds), and TCF7L2 (a glucose-homeostasis factor) shape the metabolic starting line. They are pathway-level and do not predict response to any specific compound, but they explain part of the variability a program alone cannot.

PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols — Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral. Before starting any weight-loss protocol, the Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, including FTO, MC4R, TCF7L2. That is the test before you invest approach, turning guesswork into an informed conversation with your provider.

Not affiliated: PlexusDx is not affiliated with Remedy Meds and has no commercial relationship with the companies reviewed in this article.

Related reading on PlexusDx: Tirzepatide For Weight Loss, Best GLP 1 For Weight Loss, Wagobi For Weight Loss, Semaglutide Weight Loss Injections.

Disclaimer: This article is educational. PlexusDx is not affiliated with Remedy Meds and has no commercial relationship with the companies reviewed. PlexusDx offers semaglutide and tirzepatide through its own Weight Management Protocols, and this review compares approaches in the GLP-1 telehealth space. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways; it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

Compare the PlexusDx approach: see the Weight Management Protocols for semaglutide and tirzepatide with genetic context, or take the Precision Peptide Genetic Test to understand your GLP-1 pathway first.

Frequently Asked Questions

What medications does the Remedy Meds weight-loss program use?

Prescribing draws on the incretin class, including GLP-1 receptor agonists like semaglutide and the dual GIP/GLP-1 agonist tirzepatide. Because Remedy uses a compounding pharmacy, these are often dispensed as compounded products; confirm which specific medications a plan offers on the brand's own site.

Who provides clinical oversight?

A licensed clinician evaluates eligibility before any prescription, and telehealth follow-up supports titration and side-effect management afterward. Provider type varies across programs, so verifying licensure and the credentials of the prescribing clinician on the brand's own site is a reasonable step before enrolling.

How fast does weight loss happen on these programs?

Timelines differ widely because dose escalation is gradual and individual biology varies. Clinical trials such as STEP and SURMOUNT report outcomes over months, not weeks, and real-world results depend on adherence, dose, and personal metabolic factors that no program can fully predict.

Why should I consider genetics before starting?

Genetic variants such as FTO and MC4R, and TCF7L2 shape your baseline metabolic biology. The Precision Peptide Genetic Test maps these pathway-level markers so you and your provider can discuss a weight-loss plan with more context, though it does not predict response to any specific medication.

Keep reading in the PlexusDx Education Hub. Browse all Peptides & GLP-1 education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.